Skip to main content
. 2020 Mar 13;6(11):eaax8429. doi: 10.1126/sciadv.aax8429

Fig. 1. Treatment with Recruitment-MP (50 mg) prolongs allograft survival indefinitely.

Fig. 1

(A) Hindlimb allograft survival curve showing indefinite survival (>200 days) in six of eight rats treated with Recruitment-MP (50 mg). These results are statistically significant (P < 0.05) when compared to all other groups using a log-rank test. (B) Macroscopically, treatment with 50 mg of Recruitment-MP results in acceptance of the graft with normal hair grown and gross skin appearance, as opposed to controls that exhibit hair loss and skin necrosis. Photo credit: James D. Fisher, University of Pittsburgh.